Clinical Significance of the Cystic Phenotype in Alport Syndrome.

Alport Syndrome Autosomal dominant Alport Syndrome COL4A3 COL4A4 COL4A5 variants Cystic kidney disease Genetic kidney disease IgA Nephropathy and kidney cysts Kidney cysts

Journal

American journal of kidney diseases : the official journal of the National Kidney Foundation
ISSN: 1523-6838
Titre abrégé: Am J Kidney Dis
Pays: United States
ID NLM: 8110075

Informations de publication

Date de publication:
19 Mar 2024
Historique:
received: 21 09 2023
revised: 16 01 2024
accepted: 02 02 2024
medline: 22 3 2024
pubmed: 22 3 2024
entrez: 21 3 2024
Statut: aheadofprint

Résumé

Alport Syndrome (AS) is the most common genetic glomerular disease caused by mutations that affect Type IV collagen. However, the clinical characteristics and significance of AS with kidney cysts are not well defined. This study investigated the prevalence and clinical significance of cystic kidney phenotype in AS. Retrospective cohort study. & Participants: One hundred-eight patients with AS and a comparison cohort of 79 patients with IgA Nephropathy (IgAN). Clinical, genetic, and imaging data were collected from medical records. Cystic kidney phenotype evaluated by ultrasonography and defined as the presence of ≥3 cysts in each kidney. Demographic characteristics and eGFR at disease onset. Cystic kidney phenotype in the AS and IgAN cohorts. Time to CKD stage 3b and longitudinal changes in eGFR in the AS cohort. Logistic regression analysis to test independent strengths of associations of clinical/demographic features with the binary outcome of cystic phenotype. Survival analysis for the outcome of reaching CKD stage 3b and linear mixed models for changes in eGFR over time in the AS cohort. We studied 108 patients with AS; 76 (70%) had genetic diagnosis. Autosomal dominant AS was prevalent, accounting for 68% of patients with genetic diagnosis. Cystic kidney phenotype was observed in 38% of patients with AS and was associated with normal sized kidneys in all but 3 patients, who showed increased total kidney volume, mimicking autosomal dominant polycystic kidney disease (ADPKD). The prevalence of cystic kidney phenotype was significantly higher in patients with AS when compared to comparison group of patients with IgAN (42% vs 19%; p=0.002). Patients with cystic kidney phenotype were older and had more marked reductions in eGFR than patients without cystic changes. Among patients with AS, the cystic phenotype was associated with older age and a faster decline eGFR. Retrospective, single-center study. Cystic kidney phenotype is a common finding in AS. The cystic kidney phenotype is a common finding in AS suggesting a possible role in cystogenesis for the genetic variants that cause this disease.

Identifiants

pubmed: 38514012
pii: S0272-6386(24)00681-4
doi: 10.1053/j.ajkd.2024.02.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Letizia Zeni (L)

Division of Nephrology and Dialysis, ASST-Spedali Civili of Brescia, Brescia, Italy.

Federica Mescia (F)

Division of Nephrology and Dialysis, ASST-Spedali Civili of Brescia, Brescia, Italy; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.

Diego Toso (D)

Division of Nephrology and Dialysis, ASST-Spedali Civili of Brescia, Brescia, Italy; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.

Chiara Dordoni (C)

Clinical Genetics Unit, Department of Obstetrics and Gynaecology, ASST-Spedali Civili Brescia, Italy.

Cinzia Mazza (C)

Medical Genetics Laboratory, ASST-Spedali Civili, Brescia, Italy.

Gianfranco Savoldi (G)

Medical Genetics Laboratory, ASST-Spedali Civili, Brescia, Italy.

Laura Econimo (L)

Division of Nephrology and Dialysis, ASST-Spedali Civili of Brescia, Brescia, Italy.

Roberta Cortinovis (R)

Division of Nephrology and Dialysis, ASST-Spedali Civili of Brescia, Brescia, Italy.

Simona Fisogni (S)

Section of Pathology, Department of Molecular and Translational Medicine, ASST-Spedali Civili, University of Brescia, Brescia, Italy.

Federico Alberici (F)

Division of Nephrology and Dialysis, ASST-Spedali Civili of Brescia, Brescia, Italy; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.

Francesco Scolari (F)

Division of Nephrology and Dialysis, ASST-Spedali Civili of Brescia, Brescia, Italy; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.

Claudia Izzi (C)

Clinical Genetics Unit, Department of Obstetrics and Gynaecology, ASST-Spedali Civili Brescia, Italy; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy. Electronic address: claudia.izzi@unibs.it.

Classifications MeSH